'
The related resources bookmark allows you to jump directly to other pages on the site that contain information directly related to the topics you're currently exploring.
- Home Page
- What's New?
- Tumor Types
- Molecular Causes of Cancer
- Biological Pathways
- Therapeutic Targets
- Pipeline Molecules
- Research Education
- Research ADCs
- Research Apoptosis
- Research B cell
- Research BRAF
- Research Cancer Immunotherapy
- Research HDIs
- Research HER Pathways
- Research MET
- Research VEGF
- Why is the VEGF ligand essential throughout tumor development?
- What are the strategies for inhibiting the VEGF pathway?
- What are the effects of direct VEGF ligand inhibition?
- Why is continued VEGF inhibition important?
- Why do tumors progress?
- The role of VEGF across tumor types
- Slide decks and videos
- Glossary
- Clinical Trials
- Resources
- Contact Us
Related Resources for this page:
Share
Microvessel Density (MVD) and Progression
MVD as a prognosticator
Several studies examining the significance of tumor angiogenesis as a prognosticator have recognized an association between increasing microvessel density (MVD) and deteriorating prognosis.1 Bochner et al obtained tissue from 164 patients with invasive primary transitional cell carcinoma (TCC) of the bladder. The level of MVD in the specimens significantly predicted disease-free and overall survival in patients (P<0.0001 and P=0.0007, respectively). The authors concluded that tumor angiogenesis, determined by MVD, is an independent prognostic indicator for patients with invasive TCC of the bladder.1
Reference:
- 1.
- Bochner BH, Cote RJ, Weidner N, et al. J Natl Cancer Inst. 1995;87:1603-1612. PMID: 7563203